[Drug-induced uveitis]. / Lekarstvenno-indutsirovannyi uveit.
Vestn Oftalmol
; 137(1): 94-101, 2021.
Article
en Ru
| MEDLINE
| ID: mdl-33610156
In recent years, an increasing amount of attention has been paid to medicinal products as possible risk factors in the development of eye diseases. The frequency of diagnosed drug-induced uveitis is growing yearly, which can be attributed to the appearance of new drugs - biological agents (immune checkpoint inhibitors, BRAF and MEK inhibitors, vascular endothelial growth factor inhibitors, tumor necrosis factor-α inhibitors), as well as systemic bisphosphonates and some antiviral drugs. The time interval between the beginning of the drug use and the appearance of uveitis symptoms varies from several days to months. Common symptoms include eye pain, photophobia, the appearance of floating opacities, and reduced vision associated with active inflammatory changes in the retina and optic nerve and outcomes of those inflammations. Timely diagnosis, cancellation of the drug that caused uveitis and appointment of adequate anti-inflammatory therapy in most cases effectively stops the symptoms of the disease, which determines the relevance of attention to the prevalence, pathogenesis, diagnosis and treatment of drug-induced uveitis.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Uveítis
/
Preparaciones Farmacéuticas
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
Ru
Revista:
Vestn Oftalmol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Rusia
Pais de publicación:
Rusia